Approximately 15%-20% of the patients undergoing percutaneous coronary intervention (PCI) procedure complicate with diabetes and this patient population contin
Background Enhanced extal counterpulsation (EECP) has been demonstrated to be effective in the treatment of patients with coronary artery disease (CAD). It has